Altered redox mitochondrial biology in the neurodegenerative disorder fragile x-tremor/ataxia syndrome: Use of antioxidants in precision medicine

Molecular Medicine

Volumn 22, Issue , 2016, Pages 548-559

  Song, Gyu ^a   Napoli, Eleonora ^a   Wong, Sarah ^a   Hagerman, Randi ^b,c   Liu, Siming ^a   Tassone, Flora ^b,d   Giulivi, Cecilia ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALCOHOL; ANTIOXIDANT; ASCORBIC ACID; BIOLOGICAL MARKER; DIMETHYL SULFOXIDE; EBSELEN; EPIGALLOCATECHIN GALLATE; GLUTATHIONE PEROXIDASE; MITOCHONDRIAL DNA; QUERCETIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); TROLOX C;

ADOLESCENT; ADULT; AGED; ARTICLE; ATAXIA; CELL DENSITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE CARRIER; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG USE; ENZYME ACTIVITY; FEMALE; FIBROBLAST; FRAGILE X TREMOR ATAXIA SYNDROME; GENE DELETION; HUMAN; MALE; MIDDLE AGED; NITRATIVE STRESS; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PERSONALIZED MEDICINE; PRIORITY JOURNAL; TREMOR; YOUNG ADULT;

EID: 84989315150     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2016.00122     Document Type: Article

References (60)

1. Hagerman PJ, Hagerman RJ. (2015) Fragile X-associated tremor/ataxia syndrome. Ann. N. Y. Acad. Sci. 1338:58-70.
2. Cornish K, et al. (2005) The emerging fragile X premutation phenotype: evidence from the domain of social cognition. Brain Cogn. 57:53-60.
3. Hessl D, et al. (2005) Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation. Am. J. Med. Genet B. Neuropsychiatr. Genet. 139B: 115-21.
4. Grigsby J, et al. (2006) Impairment in the cognitive functioning of men with fragile X-associated tremor/ataxia syndrome (FXTAS). J. Neurol. Sci. 248:227-33.
5. Grigsby J, et al. (2006) Cognitive impairment in a 65-year-old male with the fragile X-associated tremor-ataxia syndrome (FXTAS). Cogn. Behav. Neurol. 19:165-71.
6. Sullivan AK, et al. (2005) Association of FMR1 repeat size with ovarian dysfunction. Hum. Reprod. 20:402-12.
7. Hagerman RJ, et al. (2001) Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology. 57:127-30.
8. Jacquemont S, et al. (2003) Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am. J. Hum. Genet. 72:869-78.
9. Bacalman S, et al. (2006) Psychiatric phenotype of the fragile X-associated tremor/ataxia syndrome (FXTAS) in males: newly described fronto-subcortical dementia. J. Clin. Psychiatry. 67:87-94.
10. Sutcliffe JS, et al. (1992) DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum. Mol. Genet. 1:397-400.
11. Pieretti M, et al. (1991) Absence of expression of the FMR-1 gene in fragile X syndrome. Cell. 66:817-22.
12. Tassone F, et al. (2000) Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA. Am. J. Med. Genet. 94:232-6.
13. Tassone F, et al. (2000) Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am. J. Hum. Genet. 66:6-15.
14. Tassone F, et al. (2007) Elevated FMR1 mRNA in premutation carriers is due to increased transcription. RNA. 13:555-62.
15. Tassone F, Iwahashi C, Hagerman PJ. (2004) FMR1 RNA within the intranuclear inclusions of fragile X-associated tremor/ataxia syndrome (FXTAS). RNA Biol. 1:103-5.
16. Hagerman R, Hagerman P. (2013) Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome. Lancet Neurol. 12:786-98.
17. Sellier C, et al. (2013) Sequestration of DROSHA and DGCR8 by Expanded CGG RNA Repeats Alters MicroRNA Processing in Fragile X-Associated Tremor/Ataxia Syndrome. Cell Rep. 3:869-80.
18. Sellier C, et al. (2010) Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients. EMBO J. 29:1248-61.
19. Berman RF, et al. (2014) Mouse models of the fragile X premutation and fragile X-associated tremor/ataxia syndrome. J. Neurodev. Disord. 6:25.
20. Napoli E, Song G, Wong S, Hagerman R, Giulivi C. (2016) Altered Bioenergetics in Primary Dermal Fibroblasts from Adult Carriers of the FMR1 Premutation Before the Onset of the Neurodegenerative Disease Fragile X-Associated Tremor/Ataxia Syndrome. Cerebellum. In press.
21. Napoli E, et al. (2011) Altered zinc transport disrupts mitochondrial protein processing/import in fragile X-associated tremor/ataxia syndrome. Hum. Mol. Genet. 20:3079-92.
22. Ariza J, et al. (2015) Dysregulated iron metabolism in the choroid plexus in fragile X-associated tremor/ataxia syndrome. Brain Res. 1598:88-96.
23. Kaplan ES, et al. (2012) Early mitochondrial abnormalities in hippocampal neurons cultured from Fmr1 pre-mutation mouse model. J. Neurochem. 123:613-21.
24. Ross-Inta C, et al. (2010) Evidence of mitochondrial dysfunction in fragile X-associated tremor/ ataxia syndrome. Biochem. J. 429:545-52.
25. Napoli E, et al. (2016) Premutation in the Fragile X Mental Retardation 1 (FMR1) Gene Affects Maternal Zn-milk and Perinatal Brain Bioenergetics and Scaffolding. Front. Neurosci. 10:159.
26. Greco CM, et al. (2006) Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain. 129:243-55.
27. Napoli E, et al. (2016) Premutation in the Fragile X Mental Retardation 1 (FMR1) Gene Affects Maternal Zn-milk and Perinatal Brain Bioenergetics and Scaffolding. Front. Neurosci. 10.
28. Wong S, Giulivi C. (2016) Autism, mitochondria and polybrominated diphenyl ether exposure. CNS Neurol. Disord. Drug Targets.
29. Johri A, Beal MF. (2012) Mitochondrial dysfunction in neurodegenerative diseases. J. Pharmacol. Exp. Ther. 342:619-30.
30. Tassone F, Pan R, Amiri K, Taylor AK, Hagerman PJ. (2008) A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations. J. Mol. Diagn. 10:43-49.
31. Suthanthiran M, et al. (1984) Hydroxyl radical scavengers inhibit human natural killer cell activity. Nature. 307:276-78.
32. Albano E, Tomasi A, Goria-Gatti L, Dianzani MU. (1988) Spin trapping of free radical species produced during the microsomal metabolism of ethanol. Chem. Biol. Interact. 65:223-34.
33. Oldfield FF, Cowan DL, Sun AY. (1991) The involvement of ethanol in the free radical reaction of 6-hydroxydopamine. Neurochem. Res. 16:83-7.
34. Ingelman-Sundberg M, Johansson I. (1984) Mechanisms of hydroxyl radical formation and ethanol oxidation by ethanol-inducible and other forms of rabbit liver microsomal cytochromes P-450. J. Biol. Chem. 259:6447-58.
35. Miller GG, Raleigh JA. (1983) Action of some hydroxyl radical scavengers on radiation-induced haemolysis. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 43:411-19.
36. Phillis JW, Estevez AY, O’Regan MH. (1998) Protective effects of the free radical scavengers, dimethyl sulfoxide and ethanol, in cerebral ischemia in gerbils. Neurosci. Lett. 244:109-11.
37. Roots R, Okada S. (1972) Protection of DNA molecules of cultured mammalian cells from radiation-induced single-strand scissions by various alcohols and SH compounds. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 21:329-42.
38. Napoli E, et al. (2013) Defective mitochondrial disulfide relay system, altered mitochondrial morphology and function in Huntington′s disease. Hum. Mol. Genet. 22:989-1004.
39. Giulivi C, et al. (2010) Mitochondrial dysfunction in autism. JAMA. 304:2389-96.
40. Napoli E, et al. (2015) Mitochondrial Citrate Transporter-dependent Metabolic Signature in the 22q11.2 Deletion Syndrome. J. Biol. Chem. 290:23240-253.
41. Napoli E, Hung C, Wong S, Giulivi C. (2013) Toxicity of the flame-retardant BDE-49 on brain mitochondria and neuronal progenitor striatal cells enhanced by a PTEN-deficient background. Toxicol. Sci. 132:196-210.
42. Kuznetsov AV, Margreiter R, Amberger A, Saks V, Grimm M. (2011) Changes in mitochondrial redox state, membrane potential and calcium precede mitochondrial dysfunction in doxorubicin-induced cell death. Biochim. Biophys. Acta. 1813:1144-52.
43. Todd PK, et al. (2013) CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome. Neuron. 78:440-55.
44. Napierala M, Michalowski D, de Mezer M, Krzyzosiak WJ. (2005) Facile FMR1 mRNA structure regulation by interruptions in CGG repeats. Nucleic Acids Res. 33:451-63.
45. Weisman-Shomer P, Cohen E, Fry M. (2000) Interruption of the fragile X syndrome expanded sequence d(CGG)(n) by interspersed d(AGG) trinucleotides diminishes the formation and stability of d(CGG)(n) tetrahelical structures. Nucleic Acids Res. 28:1535-41.
46. Sellier C, et al. (2014) The multiple molecular facets of fragile X-associated tremor/ataxia syndrome. J. Neurodev. Disord. 6:23.
47. Conca Dioguardi C, Uslu, B., Haynes, M., Kurus, M., Gul, M., Miao, D-Q., De Santis, L., Ferrari, M., Bellone, S., Santin, A., Giulivi, C., Hoffman, G., Usdin, K. and Johnson, J. (2016) Granulosa cell and oocyte mitochondrial abnormalities in a mouse model of fragile X primary ovary insufficiency. Mol. Hum. Reprod. 22:384-96.
48. Hatch AL, Gurel PS, Higgs HN. (2014) Novel roles for actin in mitochondrial fission. J. Cell. Sci. 127:4549-60.
49. Eiserich JP, et al. (1999) Microtubule dysfunction by posttranslational nitrotyrosination of alpha-tubulin: a nitric oxide-dependent mechanism of cellular injury. Proc. Natl. Acad. Sci. U. S. A. 96:6365-70.
50. Castets M, et al. (2005) FMRP interferes with the Rac1 pathway and controls actin cytoskeleton dynamics in murine fibroblasts. Hum. Mol. Genet. 14:835-44.
51. Nolze A, et al. (2013) FMRP regulates actin filament organization via the armadillo protein p0071. RNA. 19:1483-96.
52. Xu X, Forbes JG, Colombini M. (2001) Actin modulates the gating of Neurospora crassa VDAC. J. Membr. Biol. 180:73-81.
53. Dugina V, Zwaenepoel I, Gabbiani G, Clement S, Chaponnier C. (2009) Beta and gamma-cytoplasmic actins display distinct distribution and functional diversity. J. Cell. Sci. 122:2980-88.
54. Korobova F, Ramabhadran V, Higgs HN. (2013) An actin-dependent step in mitochondrial fission mediated by the ER-associated formin INF2. Science. 339:464-67.
55. Boldogh IR, Pon LA. (2006) Interactions of mitochondria with the actin cytoskeleton. Biochim. Biophys. Acta. 1763:450-62.
56. Higuchi R, et al. (2013) Actin dynamics affect mitochondrial quality control and aging in budding yeast. Curr. Biol. 23:2417-22.
57. Li J, et al. (2004) Beta-actin is required for mitochondria clustering and ROS generation in TNF-induced, caspase-independent cell death. J. Cell. Sci. 117:4673-80.
58. Anesti V, Scorrano L. (2006) The relationship between mitochondrial shape and function and the cytoskeleton. Biochim. Biophys. Acta. 1757:692-699.
59. Kapitein LC, Hoogenraad CC. (2015) Building the Neuronal Microtubule Cytoskeleton. Neuron. 87:492-506.
60. Chepelev NL, Bennitz JD, Wright JS, Smith JC, Willmore WG. (2009) Oxidative modification of citrate synthase by peroxyl radicals and protection with novel antioxidants. J. Enzyme. Inhib. Med. Chem. 24:1319-31.